HIGHLY EFFECTIVE PEGINTERFERON ALPHA-2A PLUS RIBAVIRIN COMBINATION THERAPY FOR CHRONIC HEPATITIS C IN HEMOPHILIA
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, H. J. | - |
dc.contributor.author | Lee, H. W. | - |
dc.contributor.author | Lee, J. S. | - |
dc.contributor.author | Lee, Y. J. | - |
dc.date.accessioned | 2021-10-15T05:40:17Z | - |
dc.date.available | 2021-10-15T05:40:17Z | - |
dc.date.issued | 2011-03 | - |
dc.identifier.issn | 0168-8278 | - |
dc.identifier.issn | 1600-0641 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/50279 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | ELSEVIER SCIENCE BV | - |
dc.title | HIGHLY EFFECTIVE PEGINTERFERON ALPHA-2A PLUS RIBAVIRIN COMBINATION THERAPY FOR CHRONIC HEPATITIS C IN HEMOPHILIA | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/S0168-8278(11)60440-6 | - |
dc.identifier.bibliographicCitation | JOURNAL OF HEPATOLOGY, v.54, pp S178 - S178 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000297625601018 | - |
dc.citation.endPage | S178 | - |
dc.citation.startPage | S178 | - |
dc.citation.title | JOURNAL OF HEPATOLOGY | - |
dc.citation.volume | 54 | - |
dc.type.docType | Meeting Abstract | - |
dc.publisher.location | 네델란드 | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.